Integrated BioPharma (OTCMKTS:INBP) Issues Earnings Results

Integrated BioPharma (OTCMKTS:INBP) posted its earnings results on Friday. The company reported ($0.03) earnings per share (EPS) for the quarter, Zacks reports. Integrated BioPharma had a negative net margin of 0.40% and a negative return on equity of 1.02%.

Integrated BioPharma Stock Performance

OTCMKTS INBP remained flat at $0.25 on Friday. 2,032 shares of the company were exchanged, compared to its average volume of 11,623. The stock has a market cap of $7.74 million, a price-to-earnings ratio of -12.50 and a beta of 0.41. The business has a fifty day moving average of $0.28 and a 200 day moving average of $0.31. Integrated BioPharma has a 52 week low of $0.21 and a 52 week high of $0.42.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.